Biden announces new COVID initiative that gives Americans free pills By Reuters

By Nandita Bose

WASHINGTON (Reuters) -U.S. President Joe Biden on Tuesday said his administration has launched a new initiative that will allow Americans to get tested for COVID-19 at a pharmacy and immediately receive free pills if they test positive.

“We’re launching the “Test to Treat” initiative so people can get tested at a pharmacy, and if they’re positive, receive antiviral pills on the spot, at no cost,” Biden said during his State of the Union speech.

The United States has ordered more of these treatments than any other country in the world, Biden said, adding Pfizer Inc (NYSE:) will offer the U.S. 1 million pills in March and more than double that in April.  The Pfizer pill, he said, reduces the chances of ending up in the hospital by 90%.

The Biden administration will announce on Wednesday a national preparedness plan for COVID-19, mapping out how “to move forward safely and get back to our more normal routines,” the White House said in a statement.

The White House previously said it is lifting requirements that fully vaccinated people wear masks on the White House campus, effective Tuesday. It also told federal agencies they can drop COVID-19 requirements that employees and visitors wear masks in federal buildings in much of the country.

During his speech, Biden noted the progress America has made in fighting the coronavirus but warned Americans must prepare for new variants.

“I cannot promise a new variant won’t come. But I can promise you we’ll do everything within our power to be ready if it does,” he said.

The U.S. is now in a position to deploy new vaccines within 100 days instead of months or years, he said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.